208) nd-mouth disease (FMD) in Korea since the first record in 1911 occurred between Nove |
209) They stated that this is the first record of Opisthorchis sp. |
210) This is the first record of a new type of A. |
211) In this study, we first sequenced and characterized the whol |
212) This is the first sequenced mitochondrial genome from |
213) This is the first sequenced mitochondrial genome from |
214) First, the formation of EC capillary-like |
215) First, the immunophenotyping properties an |
216) First, the prevalence of esophageal cancer |
217) The first treatment consists of cooling the bu |
218) nly used therapy currently recommended as first-line treatment for a number of neuro |
219) sound guidance and should considered as a first-line treatment option for the treatm |
220) roup tended to have a longer time for the first two cell cycles, but subsequently a |
221) In the first two postoperative months, the pressu |
222) It catalyzes the first two steps of the cytosolic formation |
223) The first was immunohistochemistry to detect v |
224) Two dynamic studies were performed; the first was over 40 minutes (3 images every |
225) oesophagus, which had not been noticed at first, was determined as cause of death. |
226) 24 days post-application, whichever came first. |
227) y, three pediatric wards were selected at first. |
228) (95.4%), complete healing occurred in the first 30 days. |
229) ochondrial respiration alterations at the first 30 min, it seems that there is one o |
230) the highest amounts eliminated during the first 5 days. |
231) dio-diaries at two time points during the first 5 weeks post-partum. |
232) d higher infant dietary intake during the first 6 months of age in the context of ma |
233) ileptic encephalopathies beginning in the first 6 months of life. |
234) mplicated AMI spend the majority of their first 72 hr in CCU in bed. |
235) 70% of the documented positions over the first 72 hr in the CCU. |
236) Since their first application in the treatment of skin |
237) As a first application we monitored the cytosol |
238) The first approach frames the discrete time, p |
239) tial analysis (triangular model) with the first approach to test efficacy at 174 pat |
240) In the first article in this series we explored t |
|